Skip to main content
. 2022 Oct 6:10.1002/ejhf.2669. Online ahead of print. doi: 10.1002/ejhf.2669

Table 3.

Prevented hospitalizations and excess vaccination‐related myocarditis cases with different COVID‐19 vaccines 35

Age and sex groups Hospitalizations prevented Excess vaccine‐related myocarditis cases
All 18–39 years old
mRNA‐1273 vaccine (Moderna®) 2982 33
BNT162b2 mRNA (Pfizer‐BioNTech®) 2820 24
Males 18–39 years old
mRNA‐1273 vaccine (Moderna®) 1903 68
BNT162b2 mRNA (Pfizer‐BioNTech®) 1799 47